Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer

American Journal of Pathology

Volumn 153, Issue 3, 1998, Pages 857-864

  Nakano, Kenji ^a   Watney, Elizabeth ^a   McDougall, James K ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TELOMERASE;

ADENOCARCINOMA; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

EID: 0031703757     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65627-1     Document Type: Article

References (28)

1. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995, 14:4240-4248
2. de Lange T: Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 1994, 91:2882-2885
3. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancel. Science 1994, 266:2011-2015
4. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B: The RNA component of human telomerase. Science 1995, 269:1236-1241
5. Soder Al, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN: Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 1997, 14:1013-1021
6. Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistuba II, Milchgrub S, Srivastava S, Piatyszek MA, Shay JW, Gazdar AF: Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997, 57:2373-2377
7. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996, 56:645-650
8. Blasco MA, Rizen M, Greider CW, Hanahan D: Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 1996, 12:200-204
9. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997, 90:785-795
10. Nakamura TM, Mono GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 1997, 277:955-959
11. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW: Telomerase activity in human breast tumors. J Natl Cancer Inst 1996, 88:116-122
12. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara L, Kajiyama G, Ide T: Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995, 55:2734-2736
13. Kuniyasu H, Domen T, Hamarnoto T, Yokozaki H, Yasui W, Tahara H, Tahara E: Expression of human telomerase RNA is an early event of stomach carcinogenesis. Jpn J Cancer Res 1997, 88:103-107
14. Klingelhutz AJ, Foster SA, McDougall JK: Telomerase activation by the E6 gene product of human papillomavirus type 16 Nature 1996 380:79-82
15. Anderson S, Shera K, Ihle J, Billman L, Goff B, Greer B, Tamimi H, McDougall JK, Klingelhutz AJ: Telomerase activation in cervical cancer. Am J Pathol 1997, 151:25-31
16. Belair CD, Yeager TR, Lopez PM, Reznikoff CA: Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 1997, 94:13677-13682
17. Kaur P, McDougall JK: Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J Virol 1988 62:1917-1924
18. Laborda J: 36β4 cDNA used as an estradiol-independent mRNA control is the cDNA for acidic ribosomal phosphoprotein PO. Nucleic Acid Res 1991, 19:3998
19. Sallinen P, Mieten H, Sallinen S-L, Haapasalo H, Helin H, Kononen J: Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol 1997, 150:1159-1169
20. Rushing EJ, Yashima K, Brown DF, White CL, Shay JW, Risser RC, Gazdar AF: Expression of telomerase RNA component correlates with the MIB-1 proliferation index in ependymomas. J Neuropathol Exp Neurol 1997, 56:1142-1146
21. Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R: Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res 1998, 58:622-625
22. Kilian A, Bowtell DDL, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA: Isolation of a candidate human Telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997, 6:2011-2019
23. Harrington L, Zhou W, McPhail T, Oulton R, Yeung DSK, Mar V, Bass MB, Robinson MO: Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 1997, 11:3109-3115.
24. Ramakrishnan S, Sharma HW, Farris AD, Kaufman KM, Harley JB, Collins K, Pruijn GJM, van Venrooij WJ, Martin ML, Narayanan R: Characterization of human telomerase complex. Proc Natl Acad Sci USA 1997, 94:10075-10079
25. Mandal M, Kumar R: Bcl-2 modulates telomerase activity. J Biol Chem 1997, 272:14183-14187
26. Li H, Zhao L-L, Funder JW, Liu J-P: Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 1997, 272:16729-16732
27. Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein immortal human cells inhibits telomerase activity. Proc Natl Acad Sci USA 1995, 92:12343-12346
28. Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J, Roos G: Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res 1997, 57:549-554